title: Clinical significance of immunohistochemical Bcl-2 expression in invasive breast carcinoma.
abstract: The immunohistochemical expression of bcl-2 protein, and its correlations with clinicopathological features and prognosis were studied in patients with invasive breast carcinoma. Bcl-2 positive expression significantly correlated with hormone receptor positivity and histological tumor differentiation, and inversely correlated with p53 overaccumulation. No correlation was observed between bcl-2 expression and patient age, menopausal status, tumor size, and lymph node metastasis. Survivals of stage I to III patients who had not received adjuvant hormonal therapy showed no difference between bcl-2-positive and -negative tumors, even if patients were divided as with or without adjuvant chemotherapy, or with or without nodal involvement. In consequence, immunohistochemical bcl-2-positivity correlates with positive hormone receptors and well differentiated phenotypes in invasive breast carcinoma, however, it might not predict response to adjuvant chemotherapy and not be a favorable predictive value in patients treated without adjuvant hormonal therapy.
authors: Second Department of Surgery, Gunma University School of Medicine, Maebashi, Gunma 371-8511, Japan.
authors: H
authors: H
authors: Takei
authors: T
authors: T
authors: Oyama
authors: Y
authors: Y
authors: Iino
authors: J
authors: J
authors: Horiguchi
authors: T
authors: T
authors: Hikino
authors: M
authors: M
authors: Maemura
authors: H
authors: H
authors: Nagaoka
authors: K
authors: K
authors: Iijima
authors: T
authors: T
authors: Yokoe
authors: T
authors: T
authors: Nakajima
authors: Y
authors: Y
authors: Morishita
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology* / Q000601:surgery; D002454:Cell Differentiation / Q000502:physiology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic / Q000378:metabolism; D011237:Predictive Value of Tests; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis*; D011960:Receptors, Estrogen / Q000032:analysis; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2; D011960:Receptors, Estrogen; D016159:Tumor Suppressor Protein p53